A new deep-learning AI algorithm significantly lowered false positives in lung nodule malignancy assessment while maintaining high detection rates.
Key Details
- 1Deep-learning algorithm estimated lung nodule malignancy risk using LDCT data.
- 2Trained on 16,077 nodules (1,249 malignant) from the NLST; validated on a pooled cohort of 4,146 participants and 7,794 nodules.
- 3AUC for AI model was equal or superior to PanCan: ~0.98 (1yr), 0.96 (2yr) in pooled cohort; up to 0.95 for indeterminate nodules.
- 4For size-matched nodules, AI model AUC was 0.79 vs. PanCan at 0.6.
- 5At 100% sensitivity for cancer, AI flagged 68.1% of benign nodules as low-risk vs. PanCan's 47.4% (39.4% relative reduction in false positives).
- 6Authors stress the need for prospective clinical validation before routine use.
Why It Matters
Reducing false positives in lung cancer screening can minimize unnecessary procedures, patient anxiety, and healthcare costs. Improved AI-based risk stratification stands to improve the efficiency and effectiveness of LDCT lung cancer screening programs.
Source
AuntMinnie
Related News
•AuntMinnie
AI Tool Mirai Shows Robust Performance for Interval Breast Cancer Detection
The Mirai AI model significantly improves detection of interval breast cancers in negative screening mammograms.
•Radiology Business
AI Tool Predicts Interval Breast Cancer Risk from Negative Mammograms
AI can predict interval breast cancer risk up to three years after a negative mammogram.
•Radiology Business
AI Outperforms Radiologists in Predicting Lung Cancer Treatment Response
AI tools demonstrate higher accuracy than radiologists in predicting lung cancer treatment response from imaging studies.